Will a lab test take us a step closer to "personalized medicine"? Approval of a genetic assay for drug utilization suggests so
The US Food and Drug Administration has approved a genetics-based test that detects how certain drugs are utilized in the body. The Invader UGT1A1 Molecular Assay detects variations in the gene UGT1A1, which produces an enzyme that is active in the metabolism of certain drugs, including irinotecan (Camptosar), used to treat colorectal cancer.
Recent Videos
Related Content
Major congenital malformations not linked to first trimester tetracycline use
November 22nd 2024Article
A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
